Schedule 13G ownership disclosure
Viking Therapeutics Inc
Security class unavailable · CUSIP: 92686J106
Event date: 2022-12-23
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 6.3000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001273087-23-000003
- Form type
- SC 13G
- Filer
- MILLENNIUM MANAGEMENT LLC
- CIK
- CIK 1273087
- Filed
- Jan 03, 2023
- Reporting period
- Dec 23, 2022
- Description
- Schedule 13G beneficial ownership